Intelligence for life
Your Biological
Operating
System.
The whole patient.
A clearer picture, every day.
Labs, protocols, wearables, meals and symptoms—read together, so your practice can see what changed and what needs attention.
For practices advancing healthspan. Demos available now.
A pattern to review
ApoB is rising across four draws.
72 → 77 → 90.6 → 97.5 mg/dL on at-home draws. Confirm on the next Quest panel, then review with the clinician.
Illustrative presentation of the founder’s recorded data. Select a measure to explore.
- Labs
- Protocols
- Wearables
- Nutrition
- Symptoms
Health happens
between appointments.
ILAI connects the daily record to the clinical conversation. Your team stays in control of the next step.
One record. Every part of it read against the others, every day.
Most health data lives in pieces: a lab portal, a watch, a pharmacy, a food app, a note to self. Each piece is seen alone, if at all. ILAI compares them as one record every morning and says what they mean together.
Every app holds a piece of the patient. ILAI reads it as one, every morning. Years of labs from any lab, the doses confirmed, what the watch recorded, what was eaten, what was felt. ILAI lines them up, flags what changed, says what it means for this patient, and shows the figures behind every line. Practice demonstrations are available now; first practice deployments are being prepared, and ILAI for iPhone is coming.
Ask a question. See the patient data behind the answer. ILAI answers from the patient’s own draws, doses, symptoms and wearable data, and shows the results it used beside the answer.
Recorded ILAI response · Synthetic patient
Abbreviated from the recorded answer
Across Michael's last three draws (2025-09-02, 2026-03-17, 2026-08-28), the lipid, glucose, liver and inflammation markers all rose steadily while the sex hormones all fell.
- ApoB 118 → 125 → 132 mg/dL; triglycerides 218 → 238 → 252 mg/dL
- HbA1c 5.8 → 6.1 → 6.3%, inside the prediabetes range
- ALT 52 → 58 → 64 U/L; hs-CRP 2.8 → 3.4 → 3.9 mg/L
- Total testosterone 348 → 312 → 298 ng/dL
Checks it suggests before the next draw: iron studies with ferritin, a CBC so FIB-4 can be calculated, LH, FSH and prolactin, TSH, a urine albumin-to-creatinine ratio, and Lp(a) if it has never been measured. It closes by saying a clinician should review these results before the next scheduled draw.
Across Michael's last three draws (2025-09-02, 2026-03-17, 2026-08-28), the lipid, glucose, liver, and inflammation markers all rose steadily while the sex hormones all fell.
No marker in these clusters reversed direction. The only mixed signals are HDL, which moved from 35 to 33 to 34 mg/dL, and Vitamin D, which moved from 24 to 22 to 26 ng/mL. Both stayed out of range.
| Date | LDL (mg/dL) | ApoB (mg/dL) | Non-HDL (mg/dL) | Triglycerides (mg/dL) | HDL (mg/dL) |
|---|---|---|---|---|---|
| 2025-09-02 | 154 | 118 | 197 | 218 | 35 |
| 2026-03-17 | 162 | 125 | 208 | 238 | 33 |
| 2026-08-28 | 168 | 132 | 211 | 252 | 34 |
Triglycerides kept climbing even though Michael takes 2 g of fish oil daily. The latest triglyceride-to-HDL ratio is about 7.4 (252 / 34), which usually goes along with insulin resistance.
| Date | Glucose (mg/dL) | HbA1c (%) | Insulin (µIU/mL) | ALT (U/L) | AST (U/L) | hs-CRP (mg/L) |
|---|---|---|---|---|---|---|
| 2025-09-02 | 104 | 5.8 | 14.2 | 52 | 34 | 2.8 |
| 2026-03-17 | 108 | 6.1 | 17.8 | 58 | 38 | 3.4 |
| 2026-08-28 | 112 | 6.3 | 19.5 | 64 | 42 | 3.9 |
HbA1c is now 6.3%. That is inside the prediabetes range and 0.2 points below the diabetes cutoff of 6.5%. The fasting glucose and insulin values give an estimated HOMA-IR of about 3.6, then 4.7, then 5.4. GGT was only measured twice, but it also rose, from 62 to 71 U/L. Rising ALT, AST, and GGT together with insulin resistance fit a fatty-liver pattern, but these labs can't confirm it.
| Date | Total T (ng/dL) | Free T (pg/mL) | SHBG (nmol/L) | Estradiol (pg/mL) |
|---|---|---|---|---|
| 2025-09-02 | 348 | 7.2 | 48 | 28 |
| 2026-03-17 | 312 | 6.4 | 42 | 22 |
| 2026-08-28 | 298 | 5.8 | 38 | 18 |
LH (3.2 mIU/mL) and FSH (2.8 mIU/mL) were only measured on 2026-03-17. Both are in the low-normal range, which leans toward a secondary (pituitary-side) cause of the falling testosterone rather than a testicular one. However, it's a single draw. The drop in SHBG matches the rising insulin, because insulin resistance lowers SHBG.
Some findings from outside the last three draws are also relevant:
- eGFR fell from 92 to 86 mL/min/1.73m2, and creatinine rose from 1.0 to 1.1 mg/dL (2025-02-07 to 2026-08-28).
- Ferritin was 298 ng/mL on 2025-09-02 and hasn't been rechecked.
- TSH was last measured on 2025-09-02 at 2.4 mIU/L.
- Current diastolic blood pressure is 90.18 mmHg.
Checks for the next draw so results are comparable and the gaps get filled:
- Keep the same conditions: fasting for 10–12 hours, a 7–10 am draw for testosterone, and no hard training or alcohol for 48 hours beforehand.
- Recheck ferritin and add iron, TIBC, and transferrin saturation. High ferritin alongside rising liver enzymes needs an iron-overload screen, and ferritin can also rise with inflammation.
- Add a CBC with platelets so FIB-4 can be calculated, and consider a liver ultrasound or FibroScan.
- Repeat LH and FSH, and add prolactin, to follow up on the falling total and free testosterone.
- Repeat TSH, since the last value is a year old and thyroid function affects both lipids and testosterone.
- Add a urine albumin-to-creatinine ratio, given the eGFR decline and the diastolic blood pressure of 90.
- If Lp(a) has never been measured, add it once, since ApoB is at 132 mg/dL.
- Look beyond the labs as well: alcohol intake, any new medications or supplements, weight trend (only the current 196.62 lb is on file), and sleep apnea screening, which is linked to both low testosterone and metabolic decline.
- Confirm Michael is actually taking the Vitamin D3 2000 IU. Levels are still low at 26 ng/mL, so ask the clinician whether the dose should change.
There are no clinical notes on file, so these results can't be linked to any change in diet, activity, or medication. With HbA1c close to the diabetes threshold and ApoB still rising, a clinician should review these results before the next scheduled draw.
A pattern for the clinician to review, not a diagnosis.
Today is where the facts come from. The morning brief is what ILAI makes of them.
A patient confirms a dose, logs a meal, notes a symptom or messages the practice from Today. ILAI lines each one up with the labs and the night’s data.
Behind it sits the whole record. Every morning ILAI compares it against itself: which marker moved since the last draw, which dose changed before it, what the watch and the meals of the same weeks say. The practice sees the read, with the data behind each line.

- LabsEvery result, from any lab, across years.
- DosesWhat was scheduled, and what the patient confirmed.
- WearablesWhat the watch recorded overnight.
- SymptomsIn the patient's own words.
- Check-inHow the morning feels.

Every part against the others, every morning.- The morning briefWhat changed, what it means, the one thing to do.
- Ask ILAIAnswers computed from the record, with the draws it used.
- The next requisitionThe markers the record is missing, with the reason and the price.
- Training and sleepThe day’s session and fuel, set against recovery and the labs.
Sarah’s appetite changed. Her care team needs the full picture.
Sarah, 45, takes semaglutide and hormone therapy. She logs meals by text or photo so ILAI has the facts. ILAI weighs her intake against the floors set for her, beside her weight, her activity and the nausea she reported, and says when the record disagrees with itself. On a GLP-1, falling intake is the thing to watch, and ILAI watches it between visits.
Synthetic patient. Real ILAI workflow. ILAI’s own words.






ILAI proposes. The dose stays where it is until an authorized practice account records acceptance. ILAI records which account accepted it and when. Which accounts are authorized is the practice’s own setting; ILAI checks the account role, and prescribing responsibility remains with the treating clinician. Follow Sarah in the ILAI tour → See this workflow for your practice → Interested in ILAI for yourself? Join the interest list →
Michael, 43. No active protocol. Three consecutive lab draws show a worsening pattern.
Follow his case. ILAI flags the pattern, lays the draws side by side, and drafts the next order with the reason for each test. The clinician decides.
Synthetic patient. Real ILAI workflow.




Your team reviews the next step. ILAI prepares proposed changes for review. An authorized clinician or practice administrator must accept them before they are applied. Follow Michael in the ILAI tour →
Ask across the patient’s whole history.
One question reaches across every draw, dose, wearable reading and symptom on record. ILAI computes the statistics itself, shows the draws it used, lines each change up with the dose before it, and says what the data can't answer.
- Finds the markers you namein their own history, over the window you ask
- Calculates the statisticssample size, span, slope per year and correlation
- Shows the data it usedcheckable in seconds
- Lines each change up with the protocolby date, for you to judge
- Makes gaps visibleMissing results, limited samples and assay limits



ILAI finds the pattern across visits. It names the patients who need you, and why.
A marker rising across three draws. An incomplete lab checkpoint. An unconfirmed dose. ILAI finds each one, puts the number behind it, and raises it before the visit.
Calculations you can inspect.
ILAI shows the calculation, the explanation and the results behind it.
Every result keeps its lab and method.
A trend is fitted within one lab.
A clear record for each patient.
Each answer is tied to the patient it was asked about.
See which patients need review, and why.
ILAI puts the patients who need review first and states the finding under each name: the marker, the unconfirmed dose, the floor missed, with the number behind it. The same read arrives as a one-page report every Monday.
- Who needs you, and whythe finding and the number behind it
- Doses takenagainst what was scheduled
- HRV, resting HR and sleep7 days against 30
- What the next requisition addsper patient
The Monday reportone page for the whole practice · open it
Between visits, ILAI keeps reading.
The loop ILAI runs with your practice.
- Intakeinvite · import their lab PDFs
- Requisitionwhat to draw, why, priced
- Reviewrisk per compound · every rule checked
- Amenddose changes proposed · clinician or admin accepts
- Reportprintable: protocol, labs, reads
See ILAI in action in 30 minutes.
Your practice, in their pocket. Every morning.
Every morning ILAI takes what the night recorded, asks only for what the watch could not supply, and tells the patient what changed and the one thing to do. Patients can message their practice from Today. The clinic view puts the findings that need review first; clinical decisions stay with the care team.
ILAI reads the night first. Then it asks only what it could not read.
- Known from the nightsleep, HRV, heart rate and weight from Apple Health, each against its baseline
- Only what didn't sync is askedblood pressure, SpO₂, temperature
- How's this morning?one tap, or a sentence
- A quick signal, if they wantthe questions follow the patient
- Skip it and ILAI follows uponce, on Today
It asks, backs off, and stays quiet when there's nothing to say.




Are you a patient? Bring ILAI to your clinic →
What ILAI reads for the care you provide.
In the patient's pocket.





We set up your practice. And every patient in it.
Hands-on onboarding for your practice and patients. Our team handles setup and guides each patient, or trains your staff to do it.
- Practice setupWe set up and run your practice’s own ILAI server. You tell us which patients start first.
- Patient introductionEach patient receives a personal login and guided setup from our team or your trained staff.
- Records and protocolWe import their lab PDFs and current protocol, and check each result arrives with its lab and date.
- Their iPhoneWe guide patients through ILAI, secure access and Apple Health sharing on their iPhone. Daily messages arrive in the app.
- The first morning briefOnce ILAI has the record and the first night from the watch: what changed, what it means, the one thing to do today, and the morning check-in.
- Support that staysWe support patients and staff by email. Clinical questions stay with your clinicians.
Patients need an iPhone with Apple Health; Android isn’t supported yet. The ILAI app is free and will be distributed through the App Store. ILAI runs alongside your EHR, not instead of it.
Dedicated practice environments. Clear data controls.
Approvals: ILAI proposes dose and protocol changes with the calculation behind each one. ILAI prepares proposed changes for review. Authorized practice accounts record acceptance, with who and when, and prescribing responsibility remains with the treating clinician. Nothing is applied until acceptance is recorded. A signed clinician review record is in development. How ILAI handles data →
Questions practices ask.
Is ILAI available now?
Practice demonstrations are available now. ILAI is in daily use by its founder and first patients, and we’re preparing our first practice deployments. For individuals, ILAI for iPhone is coming to the App Store.
Does it replace our EHR?
No. ILAI runs alongside it. It holds and reads the longitudinal record the EHR does not: every draw from any lab, the dose record, the wearables and the symptoms, and what they mean together. There's no direct EHR connection yet; ILAI's patient reports print for the chart.
What gets imported, and how?
Lab reports arrive as PDF from any lab that issues them, and each result keeps its lab and method, so ILAI fits a trend within one lab. Wearable data comes through Apple Health. Doses are confirmed by the patient on Today, so ILAI can line the dose record up with the labs. Quest ordering codes are built into the requisition; reading Quest's own result files directly is in development.
Which devices do patients need?
An iPhone with Apple Health and the free ILAI app, which will be distributed through the App Store. For practice deployments, we set up secure private access on each patient’s phone. Apple Watch works directly, and Oura and Whoop work through Apple Health. Android isn’t supported yet. ILAI also runs in a browser on a desktop or iPad.
Where do ILAI's messages arrive?
On Today, inside the ILAI app.
Can patients message our practice?
Patients can send a message from Today. Your team replies from the clinic page's Inbox, and the reply appears in the patient's conversation.
Who does the setup, and how long does it take?
We set up your practice’s server, import patient records and train your team. Patients receive guided onboarding from us or your trained staff. We’ll agree on a rollout schedule based on your starting group.
What happens with a critical value?
Configured rules flag recorded critical values for review, such as a systolic blood pressure of 180 or higher, a resting heart rate of 120 or higher, severe kidney impairment, and a hematocrit of 54% or higher. These checks depend on the data available and do not provide emergency monitoring; urgent findings follow your practice's own process.
Who approves changes?
ILAI proposes dose and protocol changes, with the calculation behind each one. ILAI prepares proposed changes for review. Authorized practice accounts record acceptance, with who and when, and prescribing responsibility remains with the treating clinician. Nothing is applied until acceptance is recorded. A signed clinician review record is in development.
How is it priced?
Pricing is based on the number of patients using ILAI in your practice. We’ll outline pricing for your planned rollout during the demo.
ILAI for iPhone is coming to the App Store. For your own record.
Free to download. ILAI reads your first lab report free, start to finish: what each result means, and what to raise with your clinician. A subscription adds the daily brief, Ask ILAI and your protocol record. Join the list and we’ll tell you when it’s ready.
I've managed my own health for most of my life. No one ever had the whole picture, so I built something that does.
— Barry Katzman, founder of ILAI
ILAI reads my whole record every morning, finds what moved and what moved with it, and tells me what to raise with my clinician, with the data behind it. What needs review reaches my clinician first; the clinical decisions are theirs.
Request a practice demo.
In 30 minutes, follow a patient from the pattern ILAI flags to the draw it proposes, ask ILAI a question of your own, and discuss a rollout for your practice.
Share a few details. We’ll email you to arrange your demo.